Edition:
United Kingdom

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

28.54CAD
18 May 2018
Change (% chg)

$0.49 (+1.75%)
Prev Close
$28.05
Open
$28.29
Day's High
$28.69
Day's Low
$28.29
Volume
923,168
Avg. Vol
1,440,180
52-wk High
$30.56
52-wk Low
$14.01

Chart for

About

Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment,... (more)

Overall

Beta: -0.36
Market Cap(Mil.): $5,024.01
Shares Outstanding(Mil.): 347.33
Dividend: --
Yield (%): --

Financials

  VRX.TO Industry Sector
P/E (TTM): -- 30.95 32.75
EPS (TTM): -3.27 -- --
ROI: -2.83 14.84 14.38
ROE: -24.78 16.34 16.07

Ex-Valeant, Philidor executives convicted of kickback scheme

NEW YORK A former Valeant Pharmaceuticals International Inc executive and the former chief of mail order pharmacy Philidor Rx Services were found guilty on Tuesday of defrauding Valeant through a multimillion-dollar kickback scheme.

6:44pm BST

UPDATE 2-Ex-Valeant, Philidor executives convicted of kickback scheme

NEW YORK, May 22 A former Valeant Pharmaceuticals International Inc executive and the former chief of mail order pharmacy Philidor Rx Services were found guilty on Tuesday of defrauding Valeant through a multimillion-dollar kickback scheme.

6:41pm BST

Ex-Valeant, Philidor executives found guilty of kickback scheme

NEW YORK, May 22 A former Valeant Pharmaceuticals International Inc executive and the former head of mail order pharmacy Philidor Rx Services were found guilty on Tuesday of defrauding Valeant through a multimillion-dollar kickback scheme.

4:06pm BST

BRIEF-Valeant Announces Pricing Of Private Offering Of Notes

* VALEANT - UNIT PRICED PREVIOUSLY ANNOUNCED OFFERING OF $750 MILLION AGGREGATE PRINCIPAL AMOUNT OF 8.50% UNSECURED SENIOR NOTES DUE 2027 Source text for Eikon: Further company coverage:

17 May 2018

BRIEF-Valeant To Seek Refinancing Of Its Existing Credit Agreement

May 10 Valeant Pharmaceuticals International Inc :

10 May 2018

Valeant tries to leave the past behind with name change, shares surge

Valeant Pharmaceuticals International Inc said on Tuesday it will change its name to Bausch Health Companies Inc as it seeks to distance itself from a series of scandals and accounting issues under the drug company's previous management.

08 May 2018

Valeant tries to leave the past behind with name change, shares surge

Valeant Pharmaceuticals International Inc said on Tuesday it will change its name to Bausch Health Companies Inc as it seeks to distance itself from a series of scandals and accounting issues under the drug company's previous management.

08 May 2018

UPDATE 3-Valeant tries to leave the past behind with name change, shares surge

May 8 Valeant Pharmaceuticals International Inc said on Tuesday it will change its name to Bausch Health Companies Inc as it seeks to distance itself from a series of scandals and accounting issues under the drug company's previous management.

08 May 2018

BRIEF-Valeant Reports Q1 Loss Per Share $7.68

May 8 Valeant Pharmaceuticals International Inc :

08 May 2018

BRIEF-Valeant Will Become Bausch Health Companies Inc

May 8 Valeant Pharmaceuticals International Inc :

08 May 2018

Competitors

Earnings vs. Estimates